ASCEND BY NTHRYS
Research Abroad Products

Interactomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1–12 of 200 project topics
AI-Powered PPI Network Mapping Platform for Drug Discovery
A SaaS platform that uses machine learning to predict and visualize protein-protein interactions at scale, enabling rapid identification of novel drug targets. This reduces target validation time by 60% and accelerates lead compound discovery, generating licensing revenue and subscription fees from pharma companies.
Protein-Protein Interaction Drug Target Discovery Click to view more details →
High-Throughput PPI Screening Service for Pharmaceutical Companies
A contract research service offering automated screening of thousands of protein pairs to identify clinically relevant interactions and off-target effects. Pharma companies pay per-project fees ranging from $50K-$500K, creating recurring revenue from early-stage drug development pipelines.
Protein-Protein Interaction Drug Target Discovery Click to view more details →
Spatially-Resolved PPI Analytics Software for Cellular Localization
A computational tool that maps protein-protein interactions within subcellular compartments using imaging data and deep learning, providing mechanistic insights for target validation. Biotech and pharma clients license this software annually at $100K+ per seat, with professional services adding 30% margin.
Protein-Protein Interaction Drug Target Discovery Click to view more details →
Kinase-Centric PPI Database and Query Engine Platform
A specialized SaaS database integrating validated kinase-substrate interactions with structural and functional annotations, offering real-time query tools for drug target assessment. Subscription model generates $10M+ annual ARR from 200+ pharmaceutical and biotech customers requiring kinase selectivity profiling.
Protein-Protein Interaction Drug Target Discovery Click to view more details →
Fragment-Based Drug Design PPI Validation Workflow Tool
An integrated platform combining fragment screening, PPI modeling, and binding kinetics prediction to accelerate structure-based drug design against protein-protein interaction interfaces. Enterprise licenses command $150K-$250K annually, with additional revenue from computational chemistry module subscriptions.
Protein-Protein Interaction Drug Target Discovery Click to view more details →
Multi-Omics PPI Integration Platform for Precision Medicine
A cloud-based analytics platform correlating PPIs with genomic, transcriptomic, and proteomic data to identify patient-specific drug targets and biomarkers. Hospitals and precision medicine companies license this at $200K-$500K annually, enabling personalized oncology and immunotherapy applications.
Protein-Protein Interaction Drug Target Discovery Click to view more details →
Disruptive PPI Modulation Compound Virtual Screening Suite
A proprietary computational chemistry tool that identifies small molecules capable of disrupting or enhancing specific protein-protein interactions with high selectivity and minimal off-targets. Licensing fees generate $500K+ per client annually, with royalties on approved drugs adding 2-5% of net sales.
Protein-Protein Interaction Drug Target Discovery Click to view more details →
Real-Time PPI Dynamics Monitoring Platform for Cell Biology
A live-cell imaging and AI analysis platform that quantifies temporal dynamics of PPIs in response to drugs, enabling phenotypic assessment of target engagement in minutes. Pharma R&D organizations pay $300K+ annually per license, unlocking faster hit-to-lead transitions.
Protein-Protein Interaction Drug Target Discovery Click to view more details →
Tissue-Specific PPI Context Engine for Target Prioritization
A machine learning platform that integrates tissue-specific PPI networks, expression data, and clinical biomarkers to identify targets with high efficacy and minimal toxicity across organs. Enterprise clients in pharma pay $250K-$400K annually plus performance-based bonuses on approved drug launches.
Protein-Protein Interaction Drug Target Discovery Click to view more details →
AI-Driven PPI Target Validation and Liability Assessment Service
A boutique consulting service combining PPI biochemistry assays, computational modeling, and risk analytics to validate drug targets and predict development liabilities before IND filing. Pharma sponsors pay $500K-$2M per engagement, reducing late-stage attrition rates by 20-30%.
Protein-Protein Interaction Drug Target Discovery Click to view more details →
AI-Powered Protein Interaction Prediction SaaS Platform
A cloud-based machine learning platform that predicts protein-protein interactions using neural networks trained on massive structural databases. Enables pharmaceutical companies to accelerate drug target discovery and reduce wet-lab validation costs by 60-70%.
Interactome Network Drug Design Platforms Click to view more details →
Real-Time Interactome Visualization and Analysis Dashboard
An interactive web-based tool that renders dynamic protein interaction networks with real-time filtering, clustering, and pathway enrichment analysis capabilities. Delivers recurring SaaS revenue through enterprise subscriptions while reducing drug discovery timelines by 40%.
Interactome Network Drug Design Platforms Click to view more details →